Summary

U.S. Pet Therapeutic Diet Market Summary

The U.S. pet therapeutic diet market size was estimated at USD 1.47 billion in 2024 and is projected to reach USD 2.64 billion by 2033, growing at a CAGR of 6.71% from 2025 to 2033. Some of the key growth drivers for the market include the rising prevalence of chronic health conditions among pets, such as obesity, kidney disease, and gastrointestinal disorders.

Other factors, such as growing biotechnological innovations efforts in pet nutrition, efforts for educational awareness, a rise in pet insurance coverage for prescription foods, and pet humanization, where owners seek specialized, vet-recommended nutrition, are also expected to further fuel the growth. Nestlé, a key leading player in this industry, in May 2025, unveiled a major enhancement of its R&D capabilities, specifically emphasizing biotechnology, clinical research, and deep technology, to advance precision nutrition and pet therapeutics. This strategic initiative incorporates cutting-edge methodologies such as precision fermentation, screening assays, and development of biotics, including next-generation postbiotics and synbiotics. These advances are designed to yield scientifically validated ingredients with proven bio-efficacy. They enable highly targeted nutritional solutions tailored to pets throughout their lifespan-from early life and healthy aging to therapeutic diet applications.

By streamlining its R&D structure and prioritizing high-impact projects in close alignment with commercial teams, the company aims to accelerate innovation efficiency and responsiveness. Such intensified investments in biotech and clinical research signal a push into the expanding functional and therapeutic pet nutrition sector, reflecting rising consumer demand for science-backed, health-oriented pet diets. Given the company’s standing as a leading player in the global pet care industry, these innovation efforts are likely to influence market dynamics strongly in the U.S. pet therapeutic diet segment, driving growth and setting new expectations for evidence-based dietary products designed to manage or prevent health conditions in pets.

U.S. Pet Therapeutic Diet Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. pet therapeutic diet market report based on product, pet, indication, and distribution channel:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
o Wet Food
o Dry Food
o Other products
• Pet Outlook (Revenue, USD Million, 2021 - 2033)
o Dogs
o Cats
o Other Pets
• Indication Outlook (Revenue, USD Million, 2021 - 2033)
o Renal Care
o Obesity Care
o Diabetic Care
o Dental Care
o Gastrointestinal Care
o Recovery Care
o Joint Care
o Oncology Care
o Others
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
o E-commerce
o Veterinary hospitals & clinics
o Supermarkets/Hypermarkets
o Others

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Regional Scope
1.1.2. Estimates and Forecast Timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis
1.6.2. Global Market: CAGR Calculation
1.7. Research Scope and Assumptions
1.7.1. List of Secondary Sources
1.7.2. List of Primary Sources
1.7.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Pet Therapeutic Diet Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Prevalence Of Chronic Health Conditions Among Pets
3.2.1.2. Growing Biotechnological Innovations Efforts in Pet Nutrition
3.2.1.3. Increasing Efforts for Educational Awareness
3.2.1.4. Rise in Pet Insurance Coverage for Prescription Foods
3.2.1.5. Increasing Pet Humanization
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of product
3.2.2.2. Threat of Regulatory Product Recalls
3.2.2.3. Increasing Regulatory Ambiguity
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. U.S. Pet Therapeutic Diet Market Analysis Tools
3.3.1. Porter's Analysis
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL by SWOT Analysis
3.3.3. Estimated Pet Population, by key species, 2021 - 2024
3.3.4. Pet Demographics Analysis
3.3.5. Consumer Behavior Analysis
3.3.5.1. Demographic Analysis
3.3.5.2. Consumer Trends & Preferences
3.3.5.3. Factors Affecting Buying Decisions
3.3.5.4. Consumer Service Adoption
3.3.5.5. Observations and Recommendations
Chapter 4. U.S. Pet Therapeutic Diet Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Pet Therapeutic Diet Market: Product Movement Analysis & Market Share, 2024 & 2033
4.3. Wet Food
4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
4.4. Dry Food
4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
4.5. Others
4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Pet Therapeutic Diet Market: Pet Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Pet Therapeutic Diet Market: Pet Movement Analysis & Market Share, 2024 & 2033
5.3. Dogs
5.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
5.4. Cats
5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
5.5. Others
5.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Pet Therapeutic Diet Market: Indication Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Pet Therapeutic Diet Market: Indication Movement Analysis & Market Share, 2024 & 2033
6.3. Renal Care
6.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
6.4. Obesity Care
6.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
6.5. Diabetic Care
6.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
6.6. Dental Care
6.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
6.7. Gastrointestinal Care
6.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
6.8. Recovery Care
6.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
6.9. Joint Care
6.9.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
6.10. Oncology Care
6.10.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
6.11. Others
6.11.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Pet Therapeutic Diet Market: Distribution Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Pet Therapeutic Diet Market: Distribution Channel Movement Analysis & Market Share, 2024 & 2033
7.3. E-commerce
7.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
7.4. Veterinary Hospitals & Clinics
7.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
7.5. Retail Pharmacies
7.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
7.6. Others
7.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.1.1. Market Leaders
8.1.2. Emerging Players
8.2. Heat Map Analysis/ Company Market Position Analysis, 2024
8.3. Key Company Profiles
8.3.1. Colgate-Palmolive Company (Hill's Pet Nutrition Inc.)
8.3.1.1. Company Overview
8.3.1.2. Financial Performance
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Nestlé
8.3.2.1. Company Overview
8.3.2.2. Financial Performance
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Mars Petcare (Royal Canin)
8.3.3.1. Company Overview
8.3.3.2. Financial Performance
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. General Mills Inc. (Blue Buffalo Company, Ltd.)
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Diamond Pet Foods, Inc.
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Virbac
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Farmina pet Foods
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. JustFoodForDogs
8.3.8.1. Company Overview
8.3.8.2. Financial Performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. EmerAid, LLC
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Merrick Pet Care
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. The Farmer’s Dog, Inc.
8.3.11.1. Company Overview
8.3.11.2. Financial Performance
8.3.11.3. Product Benchmarking
8.3.11.4. Strategic Initiatives
8.4. List of Other Key Market Players
Chapter 9. Key Takeaways